Copyright (c) 2010 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=ands,ebs,ency,idix,idmi,ig,iomi,mnta,rnn,sntLatest Financial News for Anadys Pharmaceuticals, Inc., EMERGENT BIOSOLUTION, Encysive Pharmaceuticals Inc, Idenix Pharmaceuticals, Inc., , IGI LABS INC, Iomai Corporation, Momenta Pharmaceuticals, Inc., REXAHN PHARMACEUTICL, SENESCO TECHen-usTue, 9 Feb 2010 10:00:00 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=132tph5on/*http%3A//www.thestreet.com/_yahoo/story/10676709/1/genoptix-momenta-shares-headed-for-gains.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/636836962Tue, 9 Feb 2010 10:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12ick2f5s/*http%3A//online.wsj.com/article/SB10001424052748703894304575047350165401086.html?ru=yahoo&mod=yahoo_hsyahoo_finance/2441028536Sat, 6 Feb 2010 01:50:56 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/100204/183619.html?.v=1CAMBRIDGE, Mass. -- Momenta Pharmaceuticals, Inc. , a biotechnology company specializing in the characterization and engineering of complex drugs, will report its financial results for the fourth quarter and year ended December 31, 2009 before the U.S. financial markets open on Thursday, February 11, 2010.yahoo_finance/414471785Thu, 4 Feb 2010 19:18:01 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/100204/snt8-k.htmlyahoo_finance/771957914Thu, 4 Feb 2010 13:23:08 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/100204/ny49028.html?.v=1Senesco Technologies, Inc. , today announced that, on February 1, 2010, Sascha P. Fedyszyn resigned from his position as the Company's Vice President of Corporate Development and Secretary to pursue other interests.  The Company's current President and Chief Executive Officer, Jack Van Hulst, will assume Mr.yahoo_finance/3614903302Thu, 4 Feb 2010 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/100202/la47939.html?.v=1Anadys Pharmaceuticals, Inc. announced today that it will present at the 12th Annual BIO CEO & Investor Conference on Tuesday, February 9, 2010 at 10:00 a.m. EST .  The conference is being held at the Waldorf-Astoria Hotel in New York.  Steve Worland, Ph.D., President and Chief Executive Officer of Anadys, will provide an overview of Anadys and its clinical development programs, ANA598 and ANA773.yahoo_finance/2896986215Tue, 2 Feb 2010 21:05:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/100201/ne47229.html?.v=1Idenix Pharmaceuticals, Inc. announced today that Idenix management will present a corporate overview at the upcoming 12th Annual BIO CEO & Investor Conference on Monday, February 8, 2010 at 9:30 a.m.yahoo_finance/970006454Mon, 1 Feb 2010 21:05:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/100201/20100201005575.html?.v=1ROCKVILLE, Md.----Rexahn Pharmaceuticals, Inc. , a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will present at the 12th Annual BIO CEO & Investor Conference on February 9, 2010, at 11:30 a.m.yahoo_finance/578524583Mon, 1 Feb 2010 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/100129/183101.html?.v=1yahoo_finance/3682611413Fri, 29 Jan 2010 16:10:29 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh46715_2010-01-26_12-45-56_lde60p171_newsml&rpc=44&type=marketsNewsyahoo_finance/3214229270Tue, 26 Jan 2010 12:45:56 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/cc/6/110506.htmlyahoo_finance/418938156Mon, 25 Jan 2010 15:17:46 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/100125/20100125005036.html?.v=1yahoo_finance/2131945423Mon, 25 Jan 2010 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh06060_2010-01-22_17-47-34_lde60l1us_newsml&rpc=44&type=marketsNewsyahoo_finance/514427082Fri, 22 Jan 2010 17:47:34 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/100122/la41996.html?.v=1yahoo_finance/1391757877Fri, 22 Jan 2010 12:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12lnfsoh6/*http%3A//www.fool.com/investing/general/2010/01/20/3-stocks-hitting-high-notes.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/644347244Wed, 20 Jan 2010 20:41:47 Etc/GMThttp://us.rd.yahoo.com/finance/external/cnbc/rss/SIG=11hme140j/*http%3A//www.cnbc.com/id/34938652/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&par=yahooyahoo_finance/1169602508Wed, 20 Jan 2010 01:40:41 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/100119/snt8-k.htmlyahoo_finance/1353547223Tue, 19 Jan 2010 13:27:44 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/100119/ny39496.html?.v=1Senesco Technologies, Inc. announced today that on January 14, 2010, it received notice from the NYSE Amex LLC stating that the exchange had accepted the Company's compliance plan and granted it an extension until April 29, 2011 to regain compliance with the NYSE's continued listing standards.  As previously disclosed, Senesco is not in compliance with Section 1003 of the NYSE company guide with stockholder's equity of less than $6,000,000 and losses from continuing operations and/or net losses in its five most recent fiscal years.  Based on this, the Company submitted a plan advising the NYSE of action it will take that it believes would bring Senesco into compliance with the NYSE's continued listing standards by the end of the extension period.  yahoo_finance/2153938507Tue, 19 Jan 2010 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/100119/20100119005582.html?.v=1yahoo_finance/1513760709Tue, 19 Jan 2010 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/100115/idix8-k.htmlyahoo_finance/3206060004Fri, 15 Jan 2010 21:07:11 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12fri1hha/*http%3A//www.fool.com/investing/small-cap/2010/01/15/a-1-in-100-investor.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/3467932577Fri, 15 Jan 2010 20:27:08 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12mco0kg4/*http%3A//www.fool.com/investing/general/2010/01/15/5-star-stocks-on-the-upswing.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/1115669709Fri, 15 Jan 2010 19:49:39 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=133vv3r82/*http%3A//www.thestreet.com/_yahoo/story/10659363/1/nexen-anadys-options-lure-bullish-traders.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1313403138Mon, 11 Jan 2010 22:12:31 Etc/GMThttp://us.rd.yahoo.com/finance/external/minyanville/rss/SIG=15nf4de00/*http%3A//www.minyanville.com/articles/health-care-conference-biotechs-announcements-phase-trials-HIV-Hepatitis-C-genes-high-blood-sugar-diabetic-neuropathy-/index/a/26312/from/yahooBig news starts to spread as health care’s biggest week begins.yahoo_finance/3927754946Mon, 11 Jan 2010 20:55:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/100111/us_idenix_pharmaceuticals_mover.html?.v=1Shares of Idenix Pharmaceuticals Inc. rose Monday after the drug maker reported positive interim study data for its prospective hepatitis C drug IDX-184.yahoo_finance/3734504636Mon, 11 Jan 2010 18:01:04 Etc/GMT